Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) active compounds. Shows potential in the synthesis of ligands targeting serotonin and dopamine receptors, which are relevant for treating neurological disorders such as depression, schizophrenia, and Parkinson’s disease. Its structure allows for selective binding and modulation of receptor activity, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in structure-activity relationship (SAR) studies to improve potency and reduce off-target effects in new therapeutic agents.